Rio P - Search Results

1

Adenine base editing efficiently restores the function of Fanconi anemia hematopoietic stem and progenitor cells.

Siegner SM, Ugalde L, Clemens A, Garcia-Garcia L, Bueren JA, Rio P, Karasu ME, Corn JE. Siegner SM, et al. Among authors: rio p. Nat Commun. 2022 Nov 12;13(1):6900. doi: 10.1038/s41467-022-34479-z. Nat Commun. 2022. PMID: 36371486 Free PMC article.

2

In vitro phenotypic correction of hematopoietic progenitors from Fanconi anemia group A knockout mice.

Río P, Segovia JC, Hanenberg H, Casado JA, Martínez J, Göttsche K, Cheng NC, Van de Vrugt HJ, Arwert F, Joenje H, Bueren JA. Río P, et al. Blood. 2002 Sep 15;100(6):2032-9. Blood. 2002. PMID: 12200363 Free article.

3

Purging of leukemia-contaminated bone marrow grafts using suicide adenoviral vectors: an in vivo murine experimental model.

Garcia-Castro J, Rio P, Lillo R, Garcia-Sanchez F, Segovia JC, Bueren JA. Garcia-Castro J, et al. Among authors: rio p. Gene Ther. 2003 Aug;10(16):1328-35. doi: 10.1038/sj.gt.3301993. Gene Ther. 2003. PMID: 12883529

4

Efficient engraftment of in utero transplanted mice with retrovirally transduced hematopoietic stem cells.

Rio P, Martinez-Palacio J, Ramirez A, Bueren JA, Segovia JC. Rio P, et al. Gene Ther. 2005 Feb;12(4):358-63. doi: 10.1038/sj.gt.3302419. Gene Ther. 2005. PMID: 15550924

5

A simplified approach to improve the efficiency and safety of ex vivo hematopoietic gene therapy in fanconi anemia patients.

Jacome A, Navarro S, Casado JA, Rio P, Madero L, Estella J, Sevilla J, Badell I, Ortega JJ, Olivé T, Hanenberg H, Segovia JC, Bueren JA. Jacome A, et al. Among authors: rio p. Hum Gene Ther. 2006 Feb;17(2):245-50. doi: 10.1089/hum.2006.17.245. Hum Gene Ther. 2006. PMID: 16454658

6

A comprehensive strategy for the subtyping of patients with Fanconi anaemia: conclusions from the Spanish Fanconi Anemia Research Network.

Antonio Casado J, Callén E, Jacome A, Río P, Castella M, Lobitz S, Ferro T, Muñoz A, Sevilla J, Cantalejo A, Cela E, Cervera J, Sánchez-Calero J, Badell I, Estella J, Dasí A, Olivé T, José Ortega J, Rodriguez-Villa A, Tapia M, Molinés A, Madero L, Segovia JC, Neveling K, Kalb R, Schindler D, Hanenberg H, Surrallés J, Bueren JA. Antonio Casado J, et al. Among authors: rio p. J Med Genet. 2007 Apr;44(4):241-9. doi: 10.1136/jmg.2006.044719. Epub 2006 Nov 14. J Med Genet. 2007. PMID: 17105750 Free PMC article.

7

Characteristics of lentiviral vectors harboring the proximal promoter of the vav proto-oncogene: a weak and efficient promoter for gene therapy.

Almarza E, Río P, Meza NW, Aldea M, Agirre X, Guenechea G, Segovia JC, Bueren JA. Almarza E, et al. Among authors: rio p. Mol Ther. 2007 Aug;15(8):1487-94. doi: 10.1038/sj.mt.6300213. Epub 2007 May 29. Mol Ther. 2007. PMID: 17534266 Free article.

8

In vitro and in vivo expression of human erythrocyte pyruvate kinase in erythroid cells: a gene therapy approach.

Meza NW, Quintana-Bustamante O, Puyet A, Rio P, Navarro S, Diez A, Bueren JA, Bautista JM, Segovia JC. Meza NW, et al. Among authors: rio p. Hum Gene Ther. 2007 Jun;18(6):502-14. doi: 10.1089/hum.2006.052. Hum Gene Ther. 2007. PMID: 17547515

9

FA core complex moves to chromatin.

Rio P, Bueren JA. Rio P, et al. Blood. 2008 May 15;111(10):4837-8. doi: 10.1182/blood-2008-01-134668. Blood. 2008. PMID: 18467605 Free article.

10

Relevance of the Fanconi anemia pathway in the response of human cells to trabectedin.

Casado JA, Río P, Marco E, García-Hernández V, Domingo A, Pérez L, Tercero JC, Vaquero JJ, Albella B, Gago F, Bueren JA. Casado JA, et al. Among authors: rio p. Mol Cancer Ther. 2008 May;7(5):1309-18. doi: 10.1158/1535-7163.MCT-07-2432. Mol Cancer Ther. 2008. PMID: 18483318

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

475 results

Search Page

Filters